| Primary |
| Hormone Replacement Therapy |
59.5% |
| Menopausal Symptoms |
19.6% |
| Hormone Therapy |
7.3% |
| Menopause |
3.3% |
| Vulvovaginal Dryness |
2.2% |
| Hot Flush |
1.9% |
| Osteoporosis |
1.4% |
| Atrophic Vulvovaginitis |
1.0% |
| Night Sweats |
0.9% |
| Breast Cancer |
0.3% |
| Pain |
0.3% |
| Vaginal Disorder |
0.3% |
| Vulvovaginal Pain |
0.3% |
| Glaucoma |
0.2% |
| Hysterectomy |
0.2% |
| Infertility |
0.2% |
| Oestrogen Replacement Therapy |
0.2% |
| Bladder Disorder |
0.2% |
| Breast Cancer Metastatic |
0.2% |
| Coagulopathy |
0.2% |
|
| Breast Cancer |
72.9% |
| Ovarian Cancer |
3.8% |
| Breast Cancer Female |
2.2% |
| Breast Cancer In Situ |
2.2% |
| Transient Ischaemic Attack |
1.9% |
| Breast Cancer Metastatic |
1.6% |
| Urinary Tract Infection |
1.6% |
| Vascular Dementia |
1.6% |
| Nausea |
1.3% |
| Palpitations |
1.3% |
| Vomiting |
1.3% |
| Alopecia |
0.9% |
| Breast Cancer Stage Ii |
0.9% |
| Drug Ineffective |
0.9% |
| Fatigue |
0.9% |
| Headache |
0.9% |
| Hot Flush |
0.9% |
| Progesterone Receptor Assay Positive |
0.9% |
| Speech Disorder |
0.9% |
| Urticaria |
0.9% |
|
| Secondary |
| Hormone Replacement Therapy |
73.1% |
| Menopausal Symptoms |
9.3% |
| Menopause |
8.0% |
| Hot Flush |
1.1% |
| Oestrogen Replacement Therapy |
1.1% |
| Night Sweats |
0.9% |
| Hypertension |
0.9% |
| Depression |
0.7% |
| Drug Use For Unknown Indication |
0.6% |
| Anxiety |
0.6% |
| Product Used For Unknown Indication |
0.5% |
| Osteopenia |
0.5% |
| Pain |
0.4% |
| Hormone Therapy |
0.4% |
| Osteoporosis |
0.4% |
| Diabetes Mellitus |
0.3% |
| Blood Pressure |
0.3% |
| Cardiac Disorder |
0.3% |
| Thyroid Disorder |
0.3% |
| Crying |
0.3% |
|
| Breast Cancer |
42.9% |
| Breast Cancer Female |
31.4% |
| Breast Cancer Metastatic |
9.1% |
| Ovarian Cancer |
3.4% |
| Progesterone Receptor Assay Positive |
2.4% |
| Breast Cancer In Situ |
1.7% |
| Contralateral Breast Cancer |
1.3% |
| Cerebrovascular Accident |
1.1% |
| Breast Cancer Recurrent |
0.8% |
| Weight Increased |
0.7% |
| Ovarian Cancer Metastatic |
0.7% |
| Oestrogen Receptor Assay Positive |
0.6% |
| Pain |
0.6% |
| Weight Decreased |
0.6% |
| Invasive Ductal Breast Carcinoma |
0.6% |
| Thrombosis |
0.5% |
| Osteoporosis |
0.4% |
| Uterine Leiomyoma |
0.4% |
| Uterine Polyp |
0.4% |
| Endometrial Cancer |
0.4% |
|
| Concomitant |
| Product Used For Unknown Indication |
34.6% |
| Drug Use For Unknown Indication |
8.1% |
| Pain |
5.8% |
| Osteoporosis |
5.6% |
| Depression |
5.5% |
| Hormone Replacement Therapy |
5.2% |
| Rheumatoid Arthritis |
4.2% |
| Hypertension |
4.2% |
| Menopause |
3.1% |
| Asthma |
3.0% |
| Anxiety |
2.8% |
| Gastrooesophageal Reflux Disease |
2.7% |
| Osteopenia |
2.5% |
| Fibromyalgia |
1.9% |
| Blood Cholesterol Increased |
1.9% |
| Hypersensitivity |
1.8% |
| Hypothyroidism |
1.8% |
| Crohn's Disease |
1.8% |
| Arthritis |
1.7% |
| Insomnia |
1.7% |
|
| Vomiting |
10.6% |
| Weight Increased |
9.3% |
| Weight Decreased |
8.2% |
| Nausea |
8.0% |
| Rash |
5.4% |
| Vision Blurred |
5.0% |
| Pain |
4.8% |
| White Blood Cell Count Increased |
4.8% |
| Drug Ineffective |
4.5% |
| Pain In Extremity |
4.5% |
| Urinary Tract Infection |
4.3% |
| Urticaria |
4.3% |
| Wrist Fracture |
3.9% |
| Pruritus |
3.7% |
| Somnolence |
3.2% |
| Tremor |
3.2% |
| Vaginal Haemorrhage |
3.2% |
| Fatigue |
3.0% |
| Urinary Incontinence |
3.0% |
| Wrong Technique In Drug Usage Process |
2.8% |
|
| Interacting |
| Product Used For Unknown Indication |
81.0% |
| Dyspepsia |
4.8% |
| Fungal Infection |
4.8% |
| Hypothyroidism |
4.8% |
| Rheumatoid Arthritis |
4.8% |
|
| Epistaxis |
66.7% |
| Incorrect Drug Administration Duration |
33.3% |
|
